P59.9 - Neonatal jaundice, unspecified
ICD-10: | P59.9 |
Short Description: | Neonatal jaundice, unspecified |
Long Description: | Neonatal jaundice, unspecified |
Status: | Valid for Submission |
Version: | ICD-10-CM 2023 |
Code Classification: |
P59.9 is a billable ICD-10 code used to specify a medical diagnosis of neonatal jaundice, unspecified. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.
Unspecified diagnosis codes like P59.9 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Cholestatic jaundice caused by drug
- Cholestatic jaundice syndrome
- Conjugated hyperbilirubinemia in infancy
- Elevated total bilirubin
- Finding of color of limb
- Hyperbilirubinemia
- Hypermelanosis following phototherapy for neonatal jaundice
- Increased bilirubin level
- Jaundice
- Jaundiced appearance of face
- Jaundiced appearance of limbs
- Neonatal conjugated hyperbilirubinemia
- Neonatal hyperbilirubinemia
- Neonatal hyperbilirubinemia caused by substance transmitted from mother
- Neonatal hyperbilirubinemia following total parenteral nutrition
- Neonatal jaundice
- Neonatal jaundice with Rotor's syndrome
- Neonatal unconjugated hyperbilirubinemia
- Newborn physiological jaundice
- Obstructive hyperbilirubinemia
- Physiological hyperbilirubinemia
- Prolonged newborn physiological jaundice
- Sequelae of hyperalimentation
- Unconjugated hyperbilirubinemia
- Unconjugated hyperbilirubinemia
Clinical Information
- Gilbert Disease-. a benign familial disorder, transmitted as an autosomal dominant trait. it is characterized by low-grade chronic hyperbilirubinemia with considerable daily fluctuations of the bilirubin level.
- Hyperbilirubinemia-. a condition characterized by an abnormal increase of bilirubin in the blood, which may result in jaundice. bilirubin, a breakdown product of heme, is normally excreted in the bile or further catabolized before excretion in the urine.
- Hyperbilirubinemia, Hereditary-. inborn errors of bilirubin metabolism resulting in excessive amounts of bilirubin in the circulating blood, either because of increased bilirubin production or because of delayed clearance of bilirubin from the blood.
- Hyperbilirubinemia, Neonatal-. accumulation of bilirubin, a breakdown product of heme proteins, in the blood during the first weeks of life. this may lead to neonatal jaundice. the excess bilirubin may exist in the unconjugated (indirect) or the conjugated (direct) form. the condition may be self-limiting (physiological neonatal jaundice) or pathological with toxic levels of bilirubin.
- Jaundice, Chronic Idiopathic-. a benign, autosomally recessive inherited hyperbilirubinemia characterized by the presence of a dark pigment in the centrilobular region of the liver cells. there is a functional defect in biliary excretion of bilirubin, cholephilic dyes, and porphyrins. affected persons may be asymptomatic or have vague constitutional or gastrointestinal symptoms. the liver may be slightly enlarged, and oral and intravenous cholangiography fails to visualize the biliary tract.
- Jaundice-. a clinical manifestation of hyperbilirubinemia, characterized by the yellowish staining of the skin; mucous membrane; and sclera. clinical jaundice usually is a sign of liver dysfunction.
- Jaundice, Obstructive-. jaundice, the condition with yellowish staining of the skin and mucous membranes, that is due to impaired bile flow in the biliary tract, such as intrahepatic cholestasis, or extrahepatic cholestasis.
- Weil Disease-. a severe form of leptospirosis, usually caused by leptospira interrogans serovar icterohaemorrhagiae and occasionally other serovars. it is transmitted to humans by the rat and is characterized by hemorrhagic and renal symptoms with accompanying jaundice.
- Breast Milk Jaundice|Breastmilk Jaundice|Neonatal Jaundice due to Delayed Conjugation from Breast Milk Inhibitors-. jaundice in an otherwise healthy breast-fed newborn. it appears four to seven days after birth, lasts longer than the physiologic jaundice, and there are no identifiable causes.
- Neonatal Jaundice-. jaundice that appears during the neonatal period. in the majority of cases, it appears in the first week of life and is classified as physiologic due to accelerated destruction of erythrocytes and liver immaturity. in a minority of cases it is classified as non-physiologic, appearing in the first twenty four hours after birth, and is associated with underlying diseases including hemolytic disorders, polycythemia, and cephalohematoma.
- Neonatal Hyperbilirubinemia-. increased levels of bilirubin in the blood during the neonatal period. in the majority of cases it is seen in the first week of life and usually there is no underlying disease, however, it may also occur in hemolytic diseases, infections, metabolic disorders, and liver abnormalities.
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to this diagnosis code:
Inclusion Terms
Inclusion TermsThese terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- Neonatal physiological jaundice (intense)(prolonged) NOS
Index to Diseases and Injuries References
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for this diagnosis code are found in the injuries and diseases index:
- - Jaundice (yellow) - R17
- - newborn - P59.9
- - symptomatic - R17
- - newborn - P59.9
- - Newborn (infant) (liveborn) (singleton) - Z38.2
- - hyperbilirubinemia - P59.9
- - jaundice - P59.9
Convert to ICD-9 Code
Source ICD-10 Code | Target ICD-9 Code | |
---|---|---|
P59.9 | 774.6 - Fetal/neonatal jaund NOS | |
Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code. |
Patient Education
Jaundice
Jaundice causes your skin and the whites of your eyes to turn yellow. Too much bilirubin causes jaundice. Bilirubin is a yellow chemical in hemoglobin, the substance that carries oxygen in your red blood cells. As red blood cells break down, your body builds new cells to replace them. The old ones are processed by the liver. If the liver cannot handle the blood cells as they break down, bilirubin builds up in the body and your skin may look yellow.
Many healthy babies have some jaundice during the first week of life. It usually goes away. However, jaundice can happen at any age and may be a sign of a problem. Jaundice can happen for many reasons, such as:
- Blood diseases
- Genetic syndromes
- Liver diseases, such as hepatitis or cirrhosis
- Blockage of bile ducts
- Infections
- Medicines
[Learn More in MedlinePlus]
Code History
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)